HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gadolinium contrast dose in the evaluation of central nervous system tumors.

Abstract
Many factors affect the ability to detect a CNS lesion. There is no single contrast dose that is optimal for all diseases. By understanding these factors that may affect lesion detection, the appropriate dose for specific pathologic processes may be determined.
AuthorsW T Yuh, J I Halloran, N A Mayr, D J Fisher, T M Simonson, H D Nguyen
JournalNeuroimaging clinics of North America (Neuroimaging Clin N Am) Vol. 4 Issue 1 Pg. 81-8 (Feb 1994) ISSN: 1052-5149 [Print] United States
PMID8130954 (Publication Type: Journal Article, Review)
Chemical References
  • Contrast Media
  • Gadolinium
Topics
  • Central Nervous System Neoplasms (diagnosis)
  • Contrast Media
  • Gadolinium
  • Humans
  • Magnetic Resonance Imaging

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: